Masseter Muscle Reduction Procedure With Radiofrequency Coagulation

Treatment of masseteric hypertrophy with botulinum toxin: A report of two cases

“…Complications from surgical excision of masseter include hematoma formation, facial nerve paralysis, infection, mouth opening limitation and sequelae from general anesthesia (3). Injection of botulinum toxin type A into the masseter muscle is first introduced by Smyth, and Moore and Wood in 1994 and considered a less invasive modality and for cosmetic sculpting of the lower face (4,5).…”

Myofascial Orofacial Pain Exacerbated after Masseteric Nerve Neurectomy

“…She reported of familiar facial pain with palpation of both masseter and temporalis mus- Surgical intervention to the masseter muscle includes surgical excision and masseteric nerve neurectomy [8,9]. First introduced by Gurney in 1947 [10], surgical reduction of the masseter has been advocated by several authors to treat masseteric muscle hypertrophy [11][12][13][14]. Park et al [12] described the application of radiofrequency coagulation in cosmetic masseter reduction and reported several complications, such as mucoserous fluid collections (4.5%), late bleeding (3.0%), infections (1.5%), long-lasting pain (0.9%), facial nerve injuries (0.6%), Stensen's duct injuries(0.3%) and limitation of temporomandibular joint movement (1.8%).…”

Botulinum toxin: The Midas touch

“…Although surgical partial excision of masseter muscle is the traditional treatment modality for this condition, often resulted in hematoma formation, facial nerve paralysis, infection, mouth opening limitation, and substantial contracture. [36] Smyth and Moore in 1994 introduced the technique of BT injection into the masseter muscle and considered BT as less invasive modality for cosmetic sculpting of the lower face. [3738] BT when injected into a muscle causes interference with the neurotransmitter mechanism producing selective paralysis and subsequent atrophy of the muscle.…”